Financial conflicts of interest in biomedical research

The need to improve the system

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians an-d researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.

Original languageEnglish (US)
Pages (from-to)607-612
Number of pages6
JournalDrug News and Perspectives
Volume23
Issue number9
DOIs
StatePublished - Nov 2010

Fingerprint

Conflict of Interest
Biomedical Research
Industry
Research Personnel
Physicians
Legislation
Medicine

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Financial conflicts of interest in biomedical research : The need to improve the system. / Wang, Amy T.; Montori, Victor Manuel; Murad, Mohammad H.

In: Drug News and Perspectives, Vol. 23, No. 9, 11.2010, p. 607-612.

Research output: Contribution to journalArticle

@article{c59aa9222b4f46918b53f1436a67291a,
title = "Financial conflicts of interest in biomedical research: The need to improve the system",
abstract = "Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians an-d researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.",
author = "Wang, {Amy T.} and Montori, {Victor Manuel} and Murad, {Mohammad H}",
year = "2010",
month = "11",
doi = "10.1358/dnp.2010.23.9.1521763",
language = "English (US)",
volume = "23",
pages = "607--612",
journal = "Drug News and Perspectives",
issn = "0214-0934",
publisher = "Prous Science",
number = "9",

}

TY - JOUR

T1 - Financial conflicts of interest in biomedical research

T2 - The need to improve the system

AU - Wang, Amy T.

AU - Montori, Victor Manuel

AU - Murad, Mohammad H

PY - 2010/11

Y1 - 2010/11

N2 - Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians an-d researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.

AB - Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a boom in collaborations between physicians, researchers, academic institutions and industry. These relationships continue to advance medical science and make meaningful progress, yet they may threaten the integrity of physicians an-d researchers and the public's trust in medicine. This article will highlight the evolution of industry relationships and conflict of interest over time, discuss methods by which industry can potentially exert effects and propose new directions for the future.

UR - http://www.scopus.com/inward/record.url?scp=79952278522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952278522&partnerID=8YFLogxK

U2 - 10.1358/dnp.2010.23.9.1521763

DO - 10.1358/dnp.2010.23.9.1521763

M3 - Article

VL - 23

SP - 607

EP - 612

JO - Drug News and Perspectives

JF - Drug News and Perspectives

SN - 0214-0934

IS - 9

ER -